Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00819819 · ClinicalTrials.gov registry record · NA
Infant Nutrition and Risk of Celiac Disease
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00819819: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT00819819 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00819819, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The study will identify a cohort of infants at risk for celiac disease that can be followed on a long term basis for investigating the natural history the celiac disease based on the pattern of early nutrition. The study will investigate possible early feeding patterns including the timing of introduction to gluten that may protect at least in part from CD development in at risk infants.
Interventions
- DIETARY_SUPPLEMENT Gluten
- DIETARY_SUPPLEMENT Gluten free diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-04 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00819819
The ClinicalTrials.gov registry entry for NCT00819819 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gluten is the first listed.
NCT00819819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00819819 about?
NCT00819819 is a clinical study titled "Infant Nutrition and Risk of Celiac Disease". The study will identify a cohort of infants at risk for celiac disease that can be followed on a long term basis for investigating the natural history the celiac disease based on the pattern of early nutrition. The study will investigate possible early feeding patterns including the timing of introd...
What is the current status of trial NCT00819819?
This trial is currently terminated. It is a NA study. The enrollment target is 80 participants. The study started on 2008-04. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00819819?
The interventions under investigation include: Gluten (DIETARY_SUPPLEMENT), Gluten free diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00819819?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.